Key facts
- IZI Medical Products’s last known valuation is $168.0M (Sep 2022).
- It has raised $25.1M; the latest was PE Growth/Expansion in Mar 2026.
- Notable investors include Paras Capital.
- IZI Medical Products has filed 1 Form D with the SEC, most recently Apr 2009 ($22.7M sold to 10 investors).
- Status: Acquired/Merged (Operating Subsidiary).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for IZI Medical Products
- ·The full record, as it builds
Funding rounds
No funding rounds for IZI Medical Products are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IZI Medical Products
Manufacturer of medical devices intended to improve procedural accuracy and patient outcomes in interventional oncology and spine care. The company offers biopsy devices, fiducial markers, vertebral augmentation systems, and image-guided surgical tools, enabling healthcare providers in radiology, oncology, and spine procedures to perform minimally invasive diagnostics and treatments with improved precision and efficiency.
- Sector
- Healthcare
- HQ
- Owings Mills, MD, United States
- Founded
- 1991
- Employees
- 70
- Website
- izimed.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
IZI Medical Products doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IZI Medical Products shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IZI Medical Products in its N-PORT filings yet. We sweep new filings monthly.